BR9810405A - Composição que compreende 5-[4-[2-(n-metil-n-2-piridil) amino) etoxi] benzil] tiazolidino-2,4-diona - Google Patents
Composição que compreende 5-[4-[2-(n-metil-n-2-piridil) amino) etoxi] benzil] tiazolidino-2,4-dionaInfo
- Publication number
- BR9810405A BR9810405A BR9810405-5A BR9810405A BR9810405A BR 9810405 A BR9810405 A BR 9810405A BR 9810405 A BR9810405 A BR 9810405A BR 9810405 A BR9810405 A BR 9810405A
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- thiazolidine
- pyridyl
- amino
- methyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
''COMPOSIçãO QUE COMPREENDE 5- [4- [2- (N-METIL-N-2-PIRIDIL) AMINO) ETOXI] BENZIL] TIAZOLIDINO-2,4-DIONA'' Composição farmacêutica que compreende o Composto (I), caracterizada pelo fato de a composição compreender de 2 a 12 mg do Composto (I) em uma forma farmaceuticamente aceitável e opcionalmente um veículo farmaceuticamente aceitável para isso, o uso de uma tal composição em medicina, processos para preparar a tal composição e uma composição intermediária útil no tal processo.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9711683.4A GB9711683D0 (en) | 1997-06-05 | 1997-06-05 | Composition |
GBGB9712851.6A GB9712851D0 (en) | 1997-06-18 | 1997-06-18 | Composition |
PCT/EP1998/003478 WO1998055122A1 (en) | 1997-06-05 | 1998-06-02 | Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9810405A true BR9810405A (pt) | 2000-08-29 |
Family
ID=26311662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9810405-5A BR9810405A (pt) | 1997-06-05 | 1998-06-02 | Composição que compreende 5-[4-[2-(n-metil-n-2-piridil) amino) etoxi] benzil] tiazolidino-2,4-diona |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP0998284A1 (pt) |
JP (1) | JP2001521553A (pt) |
KR (1) | KR20010013410A (pt) |
CN (3) | CN1526391A (pt) |
AP (1) | AP1214A (pt) |
AR (2) | AR015120A1 (pt) |
AU (1) | AU8215098A (pt) |
BG (1) | BG104048A (pt) |
BR (1) | BR9810405A (pt) |
CA (2) | CA2292629C (pt) |
CO (1) | CO4940400A1 (pt) |
DZ (1) | DZ2510A1 (pt) |
EA (1) | EA002384B1 (pt) |
GB (1) | GB9711683D0 (pt) |
HU (1) | HUP0004070A3 (pt) |
ID (1) | ID24264A (pt) |
IL (1) | IL133074A0 (pt) |
MX (1) | MXPA99011322A (pt) |
NO (2) | NO995938L (pt) |
NZ (2) | NZ523725A (pt) |
OA (1) | OA11306A (pt) |
PE (1) | PE78899A1 (pt) |
PL (1) | PL337201A1 (pt) |
SK (1) | SK164899A3 (pt) |
TR (2) | TR200002790T2 (pt) |
TW (1) | TW570797B (pt) |
UY (1) | UY25032A1 (pt) |
WO (1) | WO1998055122A1 (pt) |
ZA (2) | ZA9811572B (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ20013800A3 (cs) * | 1999-04-23 | 2002-04-17 | Smithkline Beecham Plc | Polymorf soli 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]-benzyl]thiazolidin-2,4-dionu s kyselinou maleinovou |
US20040248945A1 (en) | 1999-04-23 | 2004-12-09 | Smithkline Beecham P.L.C. | Thiazolidinedione derivative and its use as antidiabetic |
BR0009934A (pt) | 1999-04-23 | 2002-06-04 | Smithkline Beecham Plc | Produto farmacêutico |
GB0021978D0 (en) | 2000-09-07 | 2000-10-25 | Smithkline Beecham Plc | Novel pharmaceutical |
GB0127805D0 (en) * | 2001-11-20 | 2002-01-09 | Smithkline Beecham Plc | Pharmaceutical composition |
GB0129876D0 (en) * | 2001-12-13 | 2002-02-06 | Smithkline Beecham Plc | Novel pharmaceutical |
GB0129871D0 (en) * | 2001-12-13 | 2002-02-06 | Smithkline Beecham Plc | Novel pharmaceutical |
WO2003050112A1 (en) * | 2001-12-13 | 2003-06-19 | Smithkline Beecham Plc | Toluenesulfonate hydrates of a thiazolidinedione derivative |
GB0130509D0 (en) * | 2001-12-20 | 2002-02-06 | Smithkline Beecham Plc | Novel pharmaceutical |
EP2270007A1 (en) * | 2006-05-09 | 2011-01-05 | Teva Pharmaceutical Industries Ltd. | 2-N-{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2-4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate |
US7435741B2 (en) | 2006-05-09 | 2008-10-14 | Teva Pharmaceutical Industries, Ltd. | 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate |
WO2015008234A1 (en) * | 2013-07-17 | 2015-01-22 | Glenmark Pharmaceuticals S.A. | Bicyclic heterocyclic compounds as ror gamma modulators |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3856378T2 (de) * | 1987-09-04 | 2000-05-11 | Beecham Group P.L.C., Brentford | Substituierte Thiazolidindionderivate |
GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
CN1083715C (zh) * | 1994-02-10 | 2002-05-01 | 史密丝克莱恩比彻姆有限公司 | 胰岛素敏化物治疗肾病的应用 |
JPH11510508A (ja) * | 1995-08-10 | 1999-09-14 | ワーナー−ランバート・コンパニー | インシュリン非依存性真性糖尿病患者に投与される外来インシュリンの量を減らす方法 |
AU7604596A (en) * | 1995-11-17 | 1997-06-11 | Warner-Lambert Company | A method of treating myotonic dystrophy |
IL120443A (en) * | 1996-03-18 | 2000-07-16 | Sankyo Co | Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis |
JP2000514807A (ja) * | 1996-07-12 | 2000-11-07 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | レプチン耐性の新規な治療 |
-
1997
- 1997-06-05 GB GBGB9711683.4A patent/GB9711683D0/en active Pending
-
1998
- 1998-06-02 WO PCT/EP1998/003478 patent/WO1998055122A1/en not_active Application Discontinuation
- 1998-06-02 AP APAP/P/1999/001696A patent/AP1214A/en active
- 1998-06-02 NZ NZ523725A patent/NZ523725A/en unknown
- 1998-06-02 KR KR19997011411A patent/KR20010013410A/ko not_active Application Discontinuation
- 1998-06-02 TR TR2000/02790T patent/TR200002790T2/xx unknown
- 1998-06-02 HU HU0004070A patent/HUP0004070A3/hu unknown
- 1998-06-02 PL PL98337201A patent/PL337201A1/xx unknown
- 1998-06-02 CA CA002292629A patent/CA2292629C/en not_active Expired - Fee Related
- 1998-06-02 MX MXPA99011322A patent/MXPA99011322A/es unknown
- 1998-06-02 BR BR9810405-5A patent/BR9810405A/pt not_active IP Right Cessation
- 1998-06-02 IL IL13307498A patent/IL133074A0/xx unknown
- 1998-06-02 CN CNA2003101199090A patent/CN1526391A/zh active Pending
- 1998-06-02 EP EP98932144A patent/EP0998284A1/en not_active Withdrawn
- 1998-06-02 SK SK1648-99A patent/SK164899A3/sk unknown
- 1998-06-02 AU AU82150/98A patent/AU8215098A/en not_active Abandoned
- 1998-06-02 ID IDW991520A patent/ID24264A/id unknown
- 1998-06-02 CN CN98805686A patent/CN1112926C/zh not_active Expired - Lifetime
- 1998-06-02 CA CA002333352A patent/CA2333352A1/en not_active Abandoned
- 1998-06-02 EA EA199901116A patent/EA002384B1/ru not_active IP Right Cessation
- 1998-06-02 TR TR1999/02963T patent/TR199902963T2/xx unknown
- 1998-06-02 JP JP50158799A patent/JP2001521553A/ja not_active Ceased
- 1998-06-03 DZ DZ980120A patent/DZ2510A1/xx active
- 1998-06-04 UY UY25032A patent/UY25032A1/es not_active IP Right Cessation
- 1998-06-04 CO CO98031614A patent/CO4940400A1/es unknown
- 1998-06-04 AR ARP980102650A patent/AR015120A1/es not_active Application Discontinuation
- 1998-06-04 AR ARP980102649A patent/AR008198A1/es not_active Application Discontinuation
- 1998-06-04 ZA ZA9811572A patent/ZA9811572B/xx unknown
- 1998-06-04 ZA ZA9804826A patent/ZA984826B/xx unknown
- 1998-06-05 PE PE1998000466A patent/PE78899A1/es not_active Application Discontinuation
- 1998-10-23 TW TW087117536A patent/TW570797B/zh not_active IP Right Cessation
-
1999
- 1999-12-02 OA OA9900267A patent/OA11306A/en unknown
- 1999-12-03 NO NO995938A patent/NO995938L/no not_active Application Discontinuation
- 1999-12-27 BG BG104048A patent/BG104048A/bg unknown
-
2001
- 2001-09-03 NZ NZ513922A patent/NZ513922A/xx unknown
-
2002
- 2002-11-05 CN CN02149972A patent/CN1430959A/zh active Pending
-
2004
- 2004-02-20 NO NO20040738A patent/NO20040738L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9810405A (pt) | Composição que compreende 5-[4-[2-(n-metil-n-2-piridil) amino) etoxi] benzil] tiazolidino-2,4-diona | |
EA200601145A1 (ru) | Таблетка замедленного высвобождения сенсибилизатора к инсулину и других антидиабетических агентов | |
RS51343B (sr) | Nova kompozicija i njena upotreba | |
BR0108870A (pt) | Sais cloridrato de 5-[4-[2-(n-metil-n-(2-piridil) amino) etoxi] benzil] tiazolidino-2,4-diona | |
UY25304A1 (es) | Forma hidratada de maleato de rosiglitazona | |
MY135973A (en) | Modified release compositions comprising 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, optionally in the form of pharmaceutically acceptable derivative | |
BR9813604A (pt) | Hidrato de sal de ácido maleico 5-[4-[2- (n-metil-n-(2-piridil) amino) etóxi]benzil]tiazolidina-2,4-diona | |
CO4940454A1 (es) | Nuevo metodo de tratamiento | |
BR0113713A (pt) | Sal de cloridrato de 5-[4-[2-(metil-n-(2-piridil)amino)etóxi]benzil]tiazolidina -2,4-diona | |
BR0009897A (pt) | Produto farmacêutico | |
PE108199A1 (es) | Composicion farmaceutica de tiazolidindiona y sulfonilurea | |
NZ515555A (en) | Treatment of diabetes with thiazolidinedione and sulphonylurea | |
BR0009898A (pt) | Produto farmacêutico | |
PL348601A1 (en) | New pharmaceutical composition and the process for its preparation | |
BR0112981A (pt) | Sais tartarato de derivado de tiazolidinadiona | |
BR0111536A (pt) | Sal de tiazolidinediona para tratamento de diabetes mellitus | |
GB0021784D0 (en) | Novel pharmaceutical | |
AU2002343052A1 (en) | Rosiglitazone edisylates and their use as antidiabetics | |
BR0112984A (pt) | Sais tartarato de derivado de tiazolidinodiona | |
BR0112982A (pt) | Sal tartarato de derivado de tiazolidinadiona | |
BR0112983A (pt) | Sais tartarato de derivado de tiazolidinodiona | |
AP1738A (en) | Sodium salts of 5-[4-[2-(N-Methyl -N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione. | |
EA200300004A1 (ru) | Гидроиодид 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона в качестве фармацевтического препарата | |
NZ510672A (en) | Composition comprising 5-[4-[2-(N-Methyl-N-2-Pyridyl)Amino)-Ethoxy]Benzyl]Thiazolidine-2,4-Dione | |
ECSP003434A (es) | Nuevos compuestos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1912 DE 28/08/2007. |